Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Other Operating Expenses (2019 - 2025)

Silo Pharma (SILO) has disclosed Other Operating Expenses for 7 consecutive years, with $477856.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 36.64% to $477856.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, down 8.72% year-over-year, with the annual reading at -$39916.0 for FY2025, 101.66% down from the prior year.
  • Other Operating Expenses hit $477856.0 in Q4 2025 for Silo Pharma, down from $605189.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $2.2 million in Q4 2022 to a low of $308863.0 in Q2 2021.
  • Historically, Other Operating Expenses has averaged $672364.2 across 5 years, with a median of $550021.0 in 2023.
  • Biggest YoY gain for Other Operating Expenses was 642.31% in 2021; the steepest drop was 68.01% in 2021.
  • Year by year, Other Operating Expenses stood at $1.1 million in 2021, then surged by 99.05% to $2.2 million in 2022, then crashed by 61.99% to $843325.0 in 2023, then dropped by 10.57% to $754199.0 in 2024, then tumbled by 36.64% to $477856.0 in 2025.
  • Business Quant data shows Other Operating Expenses for SILO at $477856.0 in Q4 2025, $605189.0 in Q3 2025, and $547870.0 in Q2 2025.